167 related articles for article (PubMed ID: 12872343)
21. [The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma].
Chen W; Xie D; Luo JH; Wang CX; Tao Y; Zheng KL; Mei H
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):111-4. PubMed ID: 16620672
[TBL] [Abstract][Full Text] [Related]
22. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
[TBL] [Abstract][Full Text] [Related]
23. [The expression of urokinase-type plasminogen activator and its receptor in urinary transitional cell carcinoma].
Li YJ; Zheng BZ; Zhou ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):57-9. PubMed ID: 14981816
[TBL] [Abstract][Full Text] [Related]
24. Translational studies of glutathione in bladder cancer cell lines and human specimens.
Pendyala L; Velagapudi S; Toth K; Zdanowicz J; Glaves D; Slocum H; Perez R; Huben R; Creaven PJ; Raghavan D
Clin Cancer Res; 1997 May; 3(5):793-8. PubMed ID: 9815751
[TBL] [Abstract][Full Text] [Related]
25. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
[TBL] [Abstract][Full Text] [Related]
26. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
[TBL] [Abstract][Full Text] [Related]
27. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.
Inman BA; Sebo TJ; Frigola X; Dong H; Bergstralh EJ; Frank I; Fradet Y; Lacombe L; Kwon ED
Cancer; 2007 Apr; 109(8):1499-505. PubMed ID: 17340590
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia.
Visscher DW; Sloane BF; Sameni M; Babiarz JW; Jacobson J; Crissman JD
Mod Pathol; 1994 Jan; 7(1):76-81. PubMed ID: 8159656
[TBL] [Abstract][Full Text] [Related]
29. Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
Fernández MI; Bolenz C; Trojan L; Steidler A; Weiss C; Alken P; Grobholz R; Michel MS
Eur Urol; 2008 Mar; 53(3):571-8. PubMed ID: 17804149
[TBL] [Abstract][Full Text] [Related]
30. Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder.
Liu L; Zhu D; Gao R; Guo H
Urol Int; 2008; 81(1):72-6. PubMed ID: 18645275
[TBL] [Abstract][Full Text] [Related]
31. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
32. Expression of lung resistance-related protein in transitional cell carcinoma of bladder.
Zhu Y; Kong C; Zeng Y; Sun Z; Gao H
Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883
[TBL] [Abstract][Full Text] [Related]
33. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
34. [Expression of melanoma antigen gene in urinary transitional cell carcinomas].
Geng L; Yu LZ; Du P; Ma M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma.
Choi YD; Cho NH; Ahn HS; Cho KS; Cho SY; Yang WJ
J Urol; 2007 Mar; 177(3):1174-8. PubMed ID: 17296440
[TBL] [Abstract][Full Text] [Related]
36. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
37. Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis.
Tolson JP; Flad T; Gnau V; Dihazi H; Hennenlotter J; Beck A; Mueller GA; Kuczyk M; Mueller CA
Proteomics; 2006 Jan; 6(2):697-708. PubMed ID: 16252305
[TBL] [Abstract][Full Text] [Related]
38. Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis.
Sheng KH; Yao YC; Chuang SS; Wu H; Wu TF
Proteomics; 2006 Feb; 6(3):1058-65. PubMed ID: 16400682
[TBL] [Abstract][Full Text] [Related]
39. Expression of platelet-derived endothelial cell growth factor in bladder carcinoma.
Mizutani Y; Okada Y; Yoshida O
Cancer; 1997 Mar; 79(6):1190-4. PubMed ID: 9070497
[TBL] [Abstract][Full Text] [Related]
40. [Association of uPA and uPAR expression with invasive behaviors of urinary transitional cell carcinoma].
Li YJ; Zheng BZ; Zhou ZL
Ai Zheng; 2004 Jun; 23(6):704-6. PubMed ID: 15191676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
